World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
20416
World Ranking
17253
National Ranking
8645

Richard Childs publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Childs sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 420 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Childs D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Childs sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard Childs is affiliated with the National Institutes of Health in the United States and has contributed extensively to the field of medicine, particularly within immunology, oncology, infectious diseases, hematology, and molecular biology. Their research encompasses both fundamental and clinical aspects across these disciplines.

The scientist's recent publications cover various topics including COVID-19 clinical research, immunotherapy, and cellular therapies. Notable papers include:

  • Compassionate Use of Remdesivir for Patients with Severe Covid-19, 2020, New England Journal of Medicine
  • Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic, 2020, The Journal of Infectious Diseases
  • In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging, 2020, Clinical Cancer Research
  • Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial, 2021, Clinical Infectious Diseases
  • Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion, 2021, Molecular Therapy - Methods & Clinical Development

Their collaboration network includes frequent co-authors such as Robert Reger, Xin Tian, Mala Chakraborty, Georg Aue, and Anthony F. Suffredini, indicating a broad interdisciplinary research environment.

Richard Childs has published widely in several respected publication venues, with multiple contributions to the following journals:

  • Blood
  • Bone Marrow Transplantation
  • Regular and Young Investigator Award Abstracts
  • Molecular Therapy - Methods & Clinical Development
  • British Journal of Haematology

The main fields of study focus on medicine, with an emphasis on the following subfields:

  • Immunology
  • Oncology
  • Infectious Diseases
  • Hematology
  • Molecular Biology

The primary research topics include:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Genomics and Diagnostics
  • Virus-based gene therapy research

Best Publications

  • Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

    Childs R;Chernoff A;Contentin N;Bahceci E

  • High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

    Toshihiko Tanno;Natarajan V Bhanu;Patricia A Oneal;Sung-Ho Goh

  • Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation

    Kairong Cui;Chongzhi Zang;Tae-Young Roh;Dustin E. Schones

  • Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

    R. Childs;E. Clave;N. Contentin;D. Jayasekera

  • Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

    Matthew M. Hsieh;Elizabeth M. Kang;Courtney D. Fitzhugh;M. Beth Link

  • Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

    Mohammed Z H Farooqui;Janet Valdez;Sabrina Martyr;Georg Aue

  • Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

    Pawel Muranski;Andrea Boni;Claudia Wrzesinski;Deborah E Citrin

  • Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation : recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation

    Joseph H. Antin;Richard Childs;Alexandra H. Filipovich;Sergio Giralt

  • Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

    Katayoun Rezvani;Matthias Grube;Matthias Grube;Jason M. Brenchley;Jason M. Brenchley;Giuseppe Sconocchia;Giuseppe Sconocchia

  • Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples

    Wenfei Jin;Qingsong Tang;Mimi Wan;Kairong Cui

  • Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

    Maria Berg;Andreas Lundqvist;Philip McCoy;Leigh Samsel

  • Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens

    Richard W. Childs;Mattias Carlsten

  • Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect

    Richard W. Childs;Emmanuel Clave;John Tisdale;Michelle Plante

  • Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

    B N Savani;S Mielke;S Adams;M Uribe

  • Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

    Yoshiyuki Takahashi;Nanae Harashima;Sachiko Kajigaya;Hisayuki Yokoyama

  • Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.

    Takehito Igarashi;Jason Wynberg;Ramprasad Srinivasan;Brian Becknell

  • Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury.

    Hideo Yasuda;Asada Leelahavanichkul;Shinichiro Tsunoda;James W. Dear

  • Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications

    Mattias Carlsten;Richard W. Childs

  • Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

    Inhye E. Ahn;Mohammed Z. H. Farooqui;Xin Tian;Janet Valdez

  • Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

    Scott R. Solomon;Stephan Mielke;Stephan Mielke;Bipin N. Savani;Bipin N. Savani;Aldemar Montero;Aldemar Montero

Frequent Co-Authors

Andreas Lundqvist
Andreas Lundqvist Karolinska Institute
A. John Barrett
A. John Barrett National Institutes of Health
Susan F. Leitman
Susan F. Leitman National Institutes of Health
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
David F. Stroncek
David F. Stroncek National Institutes of Health
Cynthia E. Dunbar
Cynthia E. Dunbar National Institutes of Health
Neal S. Young
Neal S. Young National Institutes of Health
Nancy L. Geller
Nancy L. Geller National Institutes of Health
John F. Tisdale
John F. Tisdale National Institutes of Health
J. Philip McCoy
J. Philip McCoy National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens the door to numerous specialized fields. If you’re considering alternative routes or advancing your current qualifications, there are several online degree programs worth exploring.

For nurses aiming to rise to leadership positions, the cheapest dnp online programs allow flexibility and affordability while earning a Doctor of Nursing Practice. Pharmacists can now earn their doctorate through pharmacy school online accredited options, meeting industry standards from anywhere.

Healthcare data management is also a fast-growing field. Gaining expertise in this area is possible through an online mhi (Master in Health Information) program, which prepares graduates for high-demand health IT roles.

For those seeking quick entry into the medical industry, consider the cheapest medical billing and coding online courses, which equip you with practical skills needed by clinics and hospitals nationwide.

Each of these pathways offers unique advantages depending on your career goals, financial circumstances, and preferred area within healthcare.

Best Scientists Citing Richard Childs

Trending Scientists

Recently Published Articles